全文获取类型
收费全文 | 11930篇 |
免费 | 1229篇 |
国内免费 | 156篇 |
专业分类
耳鼻咽喉 | 127篇 |
儿科学 | 272篇 |
妇产科学 | 288篇 |
基础医学 | 1055篇 |
口腔科学 | 89篇 |
临床医学 | 1329篇 |
内科学 | 1591篇 |
皮肤病学 | 115篇 |
神经病学 | 2820篇 |
特种医学 | 133篇 |
外科学 | 1266篇 |
综合类 | 1070篇 |
现状与发展 | 1篇 |
一般理论 | 1篇 |
预防医学 | 1281篇 |
眼科学 | 95篇 |
药学 | 803篇 |
20篇 | |
中国医学 | 615篇 |
肿瘤学 | 344篇 |
出版年
2024年 | 58篇 |
2023年 | 273篇 |
2022年 | 448篇 |
2021年 | 628篇 |
2020年 | 712篇 |
2019年 | 641篇 |
2018年 | 555篇 |
2017年 | 573篇 |
2016年 | 553篇 |
2015年 | 495篇 |
2014年 | 770篇 |
2013年 | 1119篇 |
2012年 | 613篇 |
2011年 | 694篇 |
2010年 | 526篇 |
2009年 | 530篇 |
2008年 | 590篇 |
2007年 | 521篇 |
2006年 | 430篇 |
2005年 | 379篇 |
2004年 | 321篇 |
2003年 | 271篇 |
2002年 | 232篇 |
2001年 | 161篇 |
2000年 | 142篇 |
1999年 | 97篇 |
1998年 | 95篇 |
1997年 | 107篇 |
1996年 | 90篇 |
1995年 | 78篇 |
1994年 | 62篇 |
1993年 | 53篇 |
1992年 | 61篇 |
1991年 | 44篇 |
1990年 | 52篇 |
1989年 | 39篇 |
1988年 | 37篇 |
1987年 | 33篇 |
1986年 | 31篇 |
1985年 | 34篇 |
1984年 | 27篇 |
1983年 | 18篇 |
1982年 | 28篇 |
1981年 | 27篇 |
1980年 | 13篇 |
1979年 | 13篇 |
1978年 | 12篇 |
1977年 | 12篇 |
1975年 | 4篇 |
1974年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
12.
目的:探讨两种剂量的7-甲异炔诺酮(OrgOD14,利维爱)对绝经症状控制的比较。方法:60例绝经后妇女随机分为两组:①A组30例,每日口服7-甲异炔诺酮2.5mg。②B组30例,隔日口服7-甲异炔诺酮2.5mg,共6个月。观察服药前后的Kupperman评分变化及血雌二醇、促卵泡激素水平的改变。结果:两组服药后绝经症状明显改善,Kupperman评分明显降低(P<0.01),雌二醇水平显著上升(P<0.01),促卵泡激素水平明显下降(P<0.05),而两组之间差异无显著性。结论:7-甲异炔诺酮可有效地控制绝经症状,每日口服2.5mg并不比隔日口服2.5mg有较好的控制效果(除控制失眠外),故推荐隔日口服2.5mg7-甲异炔诺酮。 相似文献
13.
14.
胡卫 《保健医学研究与实践》2007,4(4):40-41
功能性消化不良是一种高发性疾病,常影响着人们的生活质量,被视为重要的消化道疾病.虽然已有达成共识的罗马标准,功能性消化不良呈现出多种多样的症状.本文尝试为临床提供治疗的选择,包括幽门螺杆菌的清除、抑酸治疗、促胃肠动力药、抗抑郁药等.总的来说,根据主要症状来选择治疗方法是可行和有效的. 相似文献
15.
Y. Graif A. Goldberg R. Tamir D. Vigiser S. Melamed 《Clinical and experimental allergy》2006,36(12):1532-1537
BACKGROUND: In allergic conditions, the degree of skin test reactivity does not always correlate with the severity of clinical symptoms. Additional factors may contribute to the reported symptom severity. OBJECTIVES: To investigate the association between the magnitude of the skin prick test (SPT) response and the reported symptom severity in patients with allergic rhinitis and the possible modifying role of psychological factors. METHODS: One hundred four patients with allergic rhinitis and 23 with non-allergic rhinitis, classified according to their SPT response to 19 aeroallergens, were asked to rate the severity of five symptoms and to indicate whether their symptoms intensified on exposure to five common aeroallergens. They also completed a psychological questionnaire. Results Reported symptom severity of allergic rhinitis did not correlate with weal size for any of the aeroallergens tested or with the number of positive responses on SPT. It was not related to patient age, sex, or education. The reported symptoms severity correlated positively (0.29, P < 0.01) with reported symptom intensification on exposure to allergens. Moreover, both outcomes were positively associated with the psychological factors of hypochondriasis (0.20, P < 0.05 and 0.18, P < 0.05, respectively), and somatic awareness (0.24, P < 0.05 and 0.33, P < 0.01, respectively), but not with neuroticism. CONCLUSIONS: The severity of symptoms experienced by patients with allergic rhinitis is apparently not related to the magnitude of SPT response, but rather to psychological factors of hypochondriasis and somatic awareness. Physicians should be aware of the contribution of psychological factors to patient perceptions of the intensity of symptoms and of the intensification of symptoms on their exposure to allergens. 相似文献
16.
17.
Riccardo Torta Carlotta Berra Luca Binaschi Roberto Borio 《Supportive care in cancer》2007,15(5):539-546
Introduction Amisulpride is a substituted benzamide that, at low doses, selectively blocks D2 and D3 presynaptic dopamine receptors, enhancing
dopaminergic transmission in frontal cortex and limbic areas. Many clinical studies versus placebo, tricyclic antidepressants
and selective serotonin reuptake inhibitors showed amisulpride antidepressant effect, supporting its safety and rapid onset
of action. In oncological population, depression is quite frequent and difficult to treat because of the particular sensitivity
of cancer patients to the antidepressants’ side effects.
Goals of work The aims of this study were to evaluate efficacy, safety and tolerability of low doses of amisulpride (50 mg) in oncological,
depressed patients during chemotheraphy.
Materials and methods One hundred six consecutive cancer outpatients with depressive symptoms were treated in a prospective, intention to treat,
4-week study, and were evaluated in single-blind with Montgomery Asberg rating scale for depression (MADRS), clinical global
impression (CGI) and dosage record treatment emergent symptom scale (DOTES) to assess side effects of treatment.
Main results After 4 weeks of treatment, scores of MADRS and CGI significantly improved (p < 0.002; p < 0.001, respectively), with a reduction of depressive symptoms concerning both emotional (such as apparent sadness, reported
sadness, inner tension, etc.) and physical cluster (such as lack of appetite, reduction in weight, tiredness and insomnia)
with good tolerability (only two patients dropped out).
Conclusions This study is the first trial on the use of amisulpride in a cohort of oncological, depressed patients during chemotherapy.
Amisulpride demonstrated high efficacy and safety. Controlled studies are needed to confirm these preliminary data. 相似文献
18.
章新亮 《江西中医学院学报》2010,22(5):10-12
《诸病源侯论》论毒邪篇幅之多,明目之清,发前人所未发,打破传统束缚,注重临床实际。如其提出毒邪判断要以阴阳为纲;毒邪向内为病重,向外为病轻;赤白为轻,青紫黑为重;过肘膝为重,以及伤肠胃心肝脾肾均有不同的症状特征,提示了六淫从化于毒,毒邪与六淫有不同表现等问题,值得一读。 相似文献
19.
TERUAKI HONGO CHIEKO WATANABE SHUICHI OKADA NORIKO INOUE SHUHEI YAJIMA YUJI FUJII TAKEHIKO OHZEKI 《Pediatrics international》2003,45(1):60-64
BACKGROUND: In an effort to improve the quality of life of children with cancer, this study analyzes the signs and symptoms at the end of life in such children. It is hoped that these data will contribute to the development of appropriate programs to address the challenges faced by these children. PROCEDURE: Between 1994 and 2000, 28 children died after treatment for cancer at Hamamatsu University Hospital, Japan. The circumstances, signs and symptoms at the end of life of these children were analyzed through their medical records. RESULTS: Of the 28 children, the underlying diseases were leukemia/lymphoma (LL group; n=11), brain tumors (BT group; n=7), and other solid tumors (OST group; n=10). Records showed poor appetite (100%), dyspnea (82.1%), pain (75.0%), fatigue (71.4%), nausea/vomiting (57.1%), constipation (46.4%) and diarrhea (21.4%) among these children. Anxiety was reported in 53.6% of the entire group of 28 children; however, no child in the BT group manifested anxiety. However, disturbance of consciousness was reported in all children in the BT group, which was significantly greater than in the other groups. Awareness, fear or acceptance of the imminence of his/her own death as indicated by verbal expression was reported in nine children (32.1%). CONCLUSIONS: Using the data obtained in the present study, we describe situations faced in the terminal care of children. It is important to address the problems revealed by this analysis in order to achieve improvements in both the physical and psychological care of children with terminal cancer. 相似文献
20.